Profilo
Fang Ni worked as the Director of Global Business Development & Licensing at F.
Hoffmann-La Roche Ltd. from 2013 to 2017.
From 2017 to 2020, Dr. Ni was a Principal at Versant Ventures (Switzerland) GmbH.
Dr. Ni then held the position of Chief Business Officer at Monte Rosa Therapeutics AG and Bright Peak Therapeutics AG.
Currently, Dr. Ni is the Chief Financial & Business Officer at Black Diamond Therapeutics, Inc. Dr. Ni obtained a doctorate degree from Purdue University.
Precedenti posizioni note di Fang Ni
| Società | Posizione | Fine |
|---|---|---|
| BLACK DIAMOND THERAPEUTICS, INC. | Direttore Finanziario/CFO | 07/10/2024 |
Versant Ventures (Switzerland) GmbH
Versant Ventures (Switzerland) GmbH Investment ManagersFinance Acts as an alternative investment manager | Analista di Private Equity | 01/08/2020 |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/11/2017 |
Bright Peak Therapeutics AG
Bright Peak Therapeutics AG BiotechnologyHealth Technology Develops immuno-oncology therapeutics | Corporate Officer/Principal | - |
Monte Rosa Therapeutics AG
Monte Rosa Therapeutics AG Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes cancer drugs that modulates protein degradation pathways | Corporate Officer/Principal | - |
Formazione di Fang Ni
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Purdue University
Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Versant Ventures (Switzerland) GmbH
Versant Ventures (Switzerland) GmbH Investment ManagersFinance Acts as an alternative investment manager | Finance |
Black Diamond Therapeutics, Inc.
Black Diamond Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops precision medicines for cancer | Health Technology |
Monte Rosa Therapeutics AG
Monte Rosa Therapeutics AG Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes cancer drugs that modulates protein degradation pathways | Health Technology |
Bright Peak Therapeutics AG
Bright Peak Therapeutics AG BiotechnologyHealth Technology Develops immuno-oncology therapeutics | Health Technology |
















